Benefits
Strength and lean body mass gains
A 12-week double-blind RCT in resistance-trained men found peak ATP® (400 mg/day) plus resistance training significantly increased muscle thickness, lean body mass, and total body strength vs placebo plus training. A pooled analysis reported a modest improvement in maximal strength with ATP supplementation, but the literature is dominated by industry-funded, single-team studies and the effect size is small, with limited independent replication.
Fatigue resistance and endurance maintenance
A single manufacturer-funded trial reported that acute peak ATP® (400 mg) helped maintain peak force output during repeated high-intensity sets — reducing fatigue rate and preserving peak torque in later sets of exhaustive exercise. This anti-fatigue mechanism is distinct from energy production support (creatine) and works through improved blood flow and reduced muscle fatigue signaling.
Blood flow and muscle vasodilation
Extracellular ATP activates P2Y purinergic receptors on endothelial cells, triggering nitric oxide and prostaglandin release that drives vasodilation in active muscle. This blood flow enhancement improves oxygen and nutrient delivery to working muscle — complementary to NO-boosting ingredients like L-citrulline but through a completely different mechanism.
Amino acid absorption (preliminary, not an established benefit)
No trial cited on this page measured amino acid absorption. Some early, uncited work suggests oral ATP might influence amino acid handling in the gut through P2Y receptor signaling on intestinal cells, but this has not been independently confirmed and should not be treated as an established benefit.
Mechanism of action
Extracellular purinergic receptor signaling
Orally consumed ATP is not primarily absorbed intact into circulation — instead, it acts as an extracellular signaling molecule in the gut and vasculature by activating P2X and P2Y purinergic receptors on intestinal epithelium, endothelial cells, and red blood cells. P2Y receptor activation triggers NO-mediated vasodilation, P2X activation enhances muscle calcium release for stronger contractions, and intestinal P2Y signaling enhances amino acid transporter activity. This extracellular signaling mechanism explains ATP's efficacy despite limited systemic absorption.
Clinical trials
Randomized, double-blind, placebo-controlled trial of peak ATP® (400 mg/day disodium ATP) + resistance training vs placebo + training in 21 resistance-trained men for 12 weeks. (Nutr Metab)
21 resistance-trained men. 12-week intervention.
Peak ATP® increased quad muscle thickness (~+1.7 cm), lean body mass (~+1.7 kg), vertical jump power (~+30%), 1RM strength vs placebo. Critical caveat: striking effect sizes for a 12-week RT trial; small sample (n=21); industry-funded (TSI Group). Effect sizes vastly exceed typical resistance training adaptations — warrants independent replication. The mechanism (oral ATP supplementation increasing extracellular ATP without raising intracellular muscle ATP) is biologically debated.
Evidence review and pooled analysis of 5 human clinical studies (2000-2022) on oral ATP supplementation effects on strength and power performance.
Pooled across 5 ATP studies.
A 2024 independent meta-analysis (5 randomized trials, 121 men) found oral ATP improved maximal strength (mean difference about 8 kg) but showed no benefit for maximum repetitions or maximum anaerobic power. Critical caveat: limited number of independent trials; substantial industry funding across the literature. Generally underwhelming evidence relative to creatine (which has hundreds of trials and Cochrane-level evidence).